VYNE
NASDAQ · Pharmaceuticals
Vyne Therapeutics Inc
$0.60
-0.01 (-1.61%)
Open$0.61
Previous Close$0.61
Day High$0.62
Day Low$0.60
52W High$1.99
52W Low$0.28
Volume—
Avg Volume197.8K
Market Cap20.80M
P/E Ratio—
EPS$-0.62
SectorPharmaceuticals
Analyst Ratings
Buy
10 analysts
Price Target
+3,123.6% upside
Current
$0.60
$0.60
Target
$19.49
$19.49
$14.75
$19.49 avg
$26.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 467.8K | 441.8K | 2.72M |
| Net Income | -21,779,755 | -18,509,706 | 604.8K |
| Profit Margin | -4,646.1% | -4,413.8% | 22.3% |
| EBITDA | -21,966,177 | -19,705,257 | 831.2K |
| Free Cash Flow | — | — | 485.0K |
| Rev Growth | +5.9% | +5.9% | -5.6% |
| Debt/Equity | — | — | 0.54 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |